Table 2.
Univariate and multivariable statistical analysis of the association between the COMT Val158Met polymorphism and a history of preexisting psychiatric disease or substance abuse with post-traumatic stress disorder (PTSD) at 6-months post-injury.
Predictor | Odds ratio (OR) [95% CI] | Predictor sig. (p) | Nagelkerke pseudo-R2 | Model sig. (p) |
---|---|---|---|---|
Univariate analysis | ||||
COMT Met158 | 0.25 [0.09–0.69] | 0.006 | 11.0% | – |
Preexisting psychiatric disorder | 6.85 [2.54–18.49] | 6.3 × 10−5 | 22.6% | – |
Substance abuse | 3.44 [1.26–9.38] | 0.016 | 8.6% | – |
Multivariable analysis | ||||
COMT Met158 | 0.32 [0.11–0.97] | 0.044 | 29.5% | 8.1 × 10−5 |
Preexisting psychiatric disorder | 5.17 [1.80–14.89] | 0.002 | – | – |
Substance abuse | 1.88 [0.60–5.88] | 0.281 |
OR >1 represents greater odds of having six-month PTSD. CI = Confidence Interval; COMT = Catechol-O-Methyltransferase; OR = Odds Ratio; PTSD = post-traumatic stress disorder.